30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Matinas BioPharma Holdings Inc (MTNB)

Track

Stock chart
Ticker: MTNB Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
STERN ADAM K
1 purchase — total 16,600 USD
Buy 21 Aug 2020
Value US$4,682,621.54 | Price 266.31 | Shares 12,572
Buy 14 May 2020
Value US$2,399,731.76 | Price 376.14 | Shares 86,878
Buy 17 Mar 2020
Value US$6,500.00 | Price 0.65 | Shares 10,000
Buy 17 Mar 2020
Value US$6,500.00 | Price 0.65 | Shares 10,000
Buy 25 Nov 2019
Value US$71,160.20 | Price 1.23 | Shares 58,000
Buy 22 Nov 2019
Value US$43,807.30 | Price 1.20 | Shares 36,500
Buy 15 Nov 2019
Value US$105,530.00 | Price 1.06 | Shares 100,000
Buy 20 Aug 2019
Value US$13,200.00 | Price 0.66 | Shares 20,000
Buy 19 Aug 2019
Value US$9,975.18 | Price 0.68 | Shares 14,650
Buy 19 Aug 2019
Value US$13,650.00 | Price 0.68 | Shares 20,000
Buy 19 Aug 2019
Value US$7,267.52 | Price 0.70 | Shares 10,400
Buy 16 Aug 2019
Value US$71,850.00 | Price 0.72 | Shares 100,000
Buy 14 Jun 2019
Value US$12,000.00 | Price 0.80 | Shares 15,000
Buy 12 Jun 2019
Value US$15,998.00 | Price 0.80 | Shares 20,000
Buy 12 Jun 2019
Value US$9,979.61 | Price 0.80 | Shares 12,487
Buy 10 Jun 2019
Value US$12,300.00 | Price 0.82 | Shares 15,000
Buy 7 Jun 2019
Value US$17,800.00 | Price 0.89 | Shares 20,000
Buy 31 May 2019
Value US$75,200.00 | Price 0.94 | Shares 80,000
Buy 16 May 2019
Value US$142,500.00 | Price 0.95 | Shares 150,000
Buy 16 May 2019
Value US$24,115.00 | Price 0.96 | Shares 25,000
Buy 16 May 2019
Value US$95,250.00 | Price 0.95 | Shares 100,000
Buy 11 Sep 2017
Value US$7,050.00 | Price 1.41 | Shares 5,000
Buy 8 Sep 2017
Value US$6,800.00 | Price 1.36 | Shares 5,000
Buy 8 Sep 2017
Value US$69,000.00 | Price 1.38 | Shares 50,000
Buy 7 Sep 2017
Value US$69,000.00 | Price 1.38 | Shares 50,000
Buy 7 Sep 2017
Value US$6,450.00 | Price 1.29 | Shares 5,000
Buy 7 Sep 2017
Value US$6,200.00 | Price 1.24 | Shares 5,000
Buy 7 Sep 2017
Value US$130,000.00 | Price 1.30 | Shares 100,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-08-24 2020-08-21 B Purchase
4.1
STERN ADAM K
Non-Executive Director
12,572 -13.2%
266.31
US$4,682,622 		12,572 -13.2% 266.31 US$4,682,622
2020-05-18 2020-05-14 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
86,878 -43.1%
376.14
US$2,399,732 		86,878 -43.1% 376.14 US$2,399,732
2020-03-18 2020-03-17 B Purchase
Jabbour Jerome D

President and CEO

Executive Director
71,334 +35.9%
428.38
US$4,459,514 		71,334 +35.9% 428.38 US$4,459,514
2020-03-18 2020-03-17 B Purchase
4.1
STERN ADAM K
Non-Executive Director
10,000 +inf%
0.65
US$6,500 		10,000 +inf% 0.65 US$6,500
2019-11-26 2019-11-25 B Purchase Kucinski Keith A

Chief Financial Officer

Officer
58,000 +158.9%
1.23
US$71,160 		58,000 +158.9% 1.23 US$71,160
2019-11-26 2019-11-22 B Purchase Kucinski Keith A

Chief Financial Officer

Officer
36,500 +inf%
1.20
US$43,807 		36,500 +inf% 1.20 US$43,807
2019-11-19 2019-11-15 B Purchase LEPORE PATRICK G Non-Executive Director
100,000 +50.0%
1.06
US$105,530 		100,000 +50.0% 1.06 US$105,530
2019-08-22 2019-08-20 B Purchase Ende Eric J Non-Executive Director
20,000 +22.4%
0.66
US$13,200 		20,000 +22.4% 0.66 US$13,200
2019-08-21 2019-08-19 B Purchase Jabbour Jerome D

President and CEO

Executive Director
14,650 +1.9%
0.68
US$9,975 		14,650 +1.9% 0.68 US$9,975
2019-08-21 2019-08-19 B Purchase Ende Eric J Non-Executive Director
20,000 +28.9%
0.68
US$13,650 		20,000 +28.9% 0.68 US$13,650
2019-08-21 2019-08-19 B Purchase STERN ADAM K Non-Executive Director
10,400 +1.3%
0.70
US$7,268 		10,400 +1.3% 0.70 US$7,268
2019-08-20 2019-08-16 B Purchase LEPORE PATRICK G Non-Executive Director
100,000 +100.0%
0.72
US$71,850 		100,000 +100.0% 0.72 US$71,850
2019-06-18 2019-06-14 B Purchase
4.1
STERN ADAM K
15,000 +0.5%
0.80
US$12,000 		15,000 +0.5% 0.80 US$12,000
2019-06-13 2019-06-12 B Purchase
4.1
STERN ADAM K
20,000 +0.6%
0.80
US$15,998 		20,000 +0.6% 0.80 US$15,998
2019-06-13 2019-06-12 B Purchase
Jabbour Jerome D

President and CEO

Executive Director
12,487 +1.6%
0.80
US$9,980 		12,487 +1.6% 0.80 US$9,980
2019-06-11 2019-06-10 B Purchase
4.1
STERN ADAM K
15,000 +0.5%
0.82
US$12,300 		15,000 +0.5% 0.82 US$12,300
2019-06-10 2019-06-07 B Purchase
4.1
STERN ADAM K
20,000 +0.6%
0.89
US$17,800 		20,000 +0.6% 0.89 US$17,800
2019-06-03 2019-05-31 B Purchase
4.1
STERN ADAM K
80,000 +2.6%
0.94
US$75,200 		80,000 +2.6% 0.94 US$75,200
2019-05-20 2019-05-16 B Purchase
4.1
STERN ADAM K
150,000 +5.1%
0.95
US$142,500 		150,000 +5.1% 0.95 US$142,500
2019-05-20 2019-05-16 B Purchase
CONRAD HERBERT J
Non-Executive Director
25,000 +16.9%
0.96
US$24,115 		25,000 +16.9% 0.96 US$24,115
2019-05-20 2019-05-16 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
100,000 +inf%
0.95
US$95,250 		100,000 +inf% 0.95 US$95,250
2017-09-15 2017-09-11 B Purchase MANNINO RAPHAEL J

Chief Scientific Officer
5,000 +0.4%
1.41
US$7,050 		5,000 +0.4% 1.41 US$7,050
2017-09-11 2017-09-08 B Purchase Rongen Roelof

Chief Executive Officer

Executive Director
5,000 +0.1%
1.36
US$6,800 		5,000 +0.1% 1.36 US$6,800
2017-09-11 2017-09-08 B Purchase STERN ADAM K
50,000 +1.4%
1.38
US$69,000 		50,000 +1.4% 1.38 US$69,000
2017-09-11 2017-09-07 B Purchase STERN ADAM K
50,000 +1.4%
1.38
US$69,000 		50,000 +1.4% 1.38 US$69,000
2017-09-07 2017-09-07 B Purchase Scibetta James S
5,000 +1.2%
1.29
US$6,450 		5,000 +1.2% 1.29 US$6,450
2017-09-07 2017-09-07 B Purchase FERRARI STEFANO
5,000 +2.5%
1.24
US$6,200 		5,000 +2.5% 1.24 US$6,200
2017-09-07 2017-09-07 B Purchase CONRAD HERBERT J
100,000 +2.6%
1.30
US$130,000 		100,000 +2.6% 1.30 US$130,000
Explore more

More insider trading research around Matinas BioPharma Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America